21st May 2021 15:37
(Alliance News) - Medical devices developer Belluscura PLC on Friday said it plans to raise GBP17.5 million in its AIM float.
The company expects its admission on London's junior market to occur on May 28. It targets a market capitalisation of GBP51.0 million.
London-based intellectual property investment firm Tekcapital PLC owns just over 15% of Belluscura.
Belluscura earlier in May said funds raised would be used to improve marketing, research new products and help secure US Food & Drug Administration product approval.
Tekcapital shares were 1.7% higher at 15.35 pence each in London on Friday afternoon.
By Eric Cunha; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
TekCapital